Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
63.70
-0.30 (-0.47%)
Sep 5, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
Neuromuscular System Drugs | 145.38M | Log In | Log In | Log In | Log In | Upgrade |
Neuromuscular System Drugs Growth | 6.68% | Log In | Log In | Log In | Log In | Upgrade |
Anti-inflammatory, Analgesic and Anti-allergic Drugs | 80.50M | Log In | Log In | Log In | Log In | Upgrade |
Anti-inflammatory, Analgesic and Anti-allergic Drugs Growth | 11.19% | Log In | Log In | Log In | Log In | Upgrade |
Other Preparations | 78.96M | Log In | Log In | Log In | Log In | Upgrade |
Other Preparations Growth | -2.28% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular System Drug | 70.09M | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular System Drug Growth | 0.86% | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal, Hepatobiliary System Drugs | 61.52M | Log In | Log In | Log In | Log In | Upgrade |
Gastrointestinal, Hepatobiliary System Drugs Growth | -12.74% | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System Drugs | 53.83M | Log In | Log In | Log In | Log In | Upgrade |
Respiratory System Drugs Growth | 7.83% | Log In | Log In | Log In | Log In | Upgrade |
Endocrine System Drugs | 39.56M | Log In | Log In | Log In | Log In | Upgrade |
Endocrine System Drugs Growth | -5.72% | Log In | Log In | Log In | Log In | Upgrade |
Vitamins and Minerals | 31.14M | Log In | Log In | Log In | Log In | Upgrade |
Vitamins and Minerals Growth | 2.88% | Log In | Log In | Log In | Log In | Upgrade |
Urinary System Drugs | 27.92M | Log In | Log In | Log In | Log In | Upgrade |
Urinary System Drugs Growth | -19.17% | Log In | Log In | Log In | Log In | Upgrade |
Other | 22.52M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 9.56% | Log In | Log In | Log In | Log In | Upgrade |
Chemotherapy Agents | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Product | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2006 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2006 - 2019 |
Taiwan | 610.54M | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 0.84% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 879.00K | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | -30.68% | Log In | Log In | Log In | Log In | Upgrade |